Kazia Therapeutics KZIA
NASDAQ KZIA
$6.62 -0.33 (-4.75%)
At close: Nov 13, 2026 · 4:00 PM EST

Kazia Therapeutics (KZIA) Share-based Compensation (IS) (2009 - 2013)

Updated

Kazia Therapeutics (KZIA) reported Share-based Compensation (IS) of -$370,415 for fiscal Q4 2013 (quarter ended Aug 30, 2013).

Analysis

Kazia Therapeutics (KZIA) Share-based Compensation (IS) (2009 - 2013) Analysis & Trends

Over the twelve months ended Aug 30, 2013, Kazia Therapeutics' Share-based Compensation (IS) came in at -$1.89 million.

  • The fiscal Q4 2013 figure ranks as the highest quarterly Share-based Compensation (IS) since fiscal Q2 2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Kazia Therapeutics 10.72 Mn -41.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Aug 30, 2013 -370,415.50
Dec 31, 2012 -515,189.70
Jun 30, 2010 -643,578.42
Dec 31, 2009 -1.09 Mn
API Access

Kazia Therapeutics Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=KZIA&period=max&api_key=YOUR_API_KEY